78686-01-8Relevant academic research and scientific papers
Isolation and characterization of an unusual nucleoside, 1-α-D- ribofuranosyl-4-pyridone-3-carboxamide, from the urines of normal human individuals and leukemic patients
Chheda,Patrzyc,Tworek,Dutta
, p. 1519 - 1537 (1995)
A novel modified nucleoside, 1-α-D-Ribofuranosyl-4-pyridone-3- carboxamide, has been isolated from the urines of one normal human individual and two CML patients. The structure was assigned on the basis of UV, NMR and mass spectral data and confirmed by comparison with an authentic sample synthesized in our laboratory. This constitutes the first example of the occurrence of a nucleoside with an α-riboside linkage in human urine.
Synthesis of methylenebis (Phosphonate) analogues of 2-, 4-, and 6-pyridones of nicotinamide adenine dinucleotide
Felczak, Krzysztof,Pankiewicz, Krzysztof W.
, p. 512 - 523 (2011)
The synthesis of metabolically stable methylenebis(phosphonate) analogues of 2-, 4-, and 6-pyridones of nicotinamide adenine dinucleotide (NAD) is reported. In contrast to natural pyrophosphates, these NAD analogues are able to penetrate the cell membrane and can be used as probes in cellular assays. Copyright Taylor and Francis Group, LLC.
Monocyclic L-nucleosides, analogs and uses thereof
-
Example 17, (2010/01/31)
Novel monocyclic L- nucleoside compounds have general formula (I). Embodiments of these compounds are contemplated to be useful in treating a wide variety of diseases including infections, infestations, neoplasms, and autoimmune diseases. Viewed in terms of mechanism, embodiments of the novel compounds show immunomodulatory activity, and are expected to be useful in modulating the cytokine pattern, including modulation of Th 1 and Th 2 response.
Monocyclic L-Nucleosides, analogs and uses thereof
-
, (2008/06/13)
Novel monocyclic L-Nucleoside compounds have the general formula STR1 Embodiments of these compounds are contemplated to be useful in treating a wide variety of diseases including infections, infestations, neoplasms, and autoimmune diseases. Viewed in terms of mechanism, embodiments of the novel compounds show immunomodulatory activity, and are expected to be useful in modulating the cytokine pattern, including modulation of Th1 and Th2 response.
